Two long‐term phase 3 studies of enarodustat (JTZ‐951) in Japanese anemic patients with chronic kidney disease not on dialysis or on maintenance hemodialysis: SYMPHONY ND‐Long and HD‐Long studies
Akizawa, Tadao, Nangaku, Masaomi, Yamaguchi, Takuhiro, Koretomo, Ryosuke, Maeda, Kazuo, Yamada, Osamu, Hirakata, Hideki
Published in Therapeutic apheresis and dialysis (01.04.2022)
Published in Therapeutic apheresis and dialysis (01.04.2022)
Get full text
Journal Article
Enarodustat, Conversion and Maintenance Therapy for Anemia in Hemodialysis Patients: A Randomized, Placebo-Controlled Phase 2b Trial Followed by Long-Term Trial
Akizawa, Tadao, Nangaku, Masaomi, Yamaguchi, Takuhiro, Arai, Masanobu, Koretomo, Ryosuke, Maeda, Kazuo, Miyazawa, Yuya, Hirakata, Hideki
Published in Nephron (2015) (2019)
Published in Nephron (2015) (2019)
Get full text
Journal Article
A Phase 3 Study of Enarodustat (JTZ-951) in Japanese Hemodialysis Patients for Treatment of Anemia in Chronic Kidney Disease: SYMPHONY HD Study
Akizawa, Tadao, Nangaku, Masaomi, Yamaguchi, Takuhiro, Koretomo, Ryosuke, Maeda, Kazuo, Miyazawa, Yuya, Hirakata, Hideki
Published in Kidney diseases (01.11.2021)
Published in Kidney diseases (01.11.2021)
Get full text
Journal Article